GTCR to Acquire Maravai LifeSciences for $3.4B
Ticker: MRVI · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1823239
| Field | Detail |
|---|---|
| Company | Maravai Lifesciences Holdings, Inc. (MRVI) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | medium |
| Sentiment | bullish |
Sentiment: bullish
Topics: acquisition, merger, private-equity
Related Tickers: MRVI
TL;DR
Maravai is being bought by GTCR for $3.4B ($22.37/share) - deal expected Q3 2025.
AI Summary
Maravai LifeSciences Holdings, Inc. announced on July 16, 2025, that it has entered into a definitive agreement to be acquired by GTCR LLC. The transaction is valued at approximately $3.4 billion, with GTCR acquiring all outstanding shares of Maravai for $22.37 per share in cash. This acquisition is expected to close in the third quarter of 2025, subject to customary closing conditions.
Why It Matters
This significant acquisition at a premium price indicates strong investor confidence in Maravai's business and its future prospects, potentially signaling a positive trend for other life sciences companies.
Risk Assessment
Risk Level: medium — The deal is subject to customary closing conditions, which introduces a level of uncertainty until completion.
Key Numbers
- $3.4B — Acquisition Value (Total price GTCR is paying for Maravai.)
- $22.37 — Per Share Price (Cash amount each Maravai shareholder will receive.)
Key Players & Entities
- Maravai LifeSciences Holdings, Inc. (company) — Company being acquired
- GTCR LLC (company) — Acquiring company
- $3.4 billion (dollar_amount) — Total transaction value
- $22.37 (dollar_amount) — Per share acquisition price
- July 16, 2025 (date) — Date of definitive agreement
- third quarter of 2025 (date) — Expected closing period
FAQ
What is the total value of the transaction?
The transaction is valued at approximately $3.4 billion.
What is the price per share being offered?
GTCR LLC is acquiring all outstanding shares of Maravai for $22.37 per share in cash.
Who is acquiring Maravai LifeSciences?
GTCR LLC is acquiring Maravai LifeSciences Holdings, Inc.
When is the acquisition expected to close?
The acquisition is expected to close in the third quarter of 2025.
What is the date of the definitive agreement?
The definitive agreement was entered into on July 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).